2 Emergent Techniologies for Early Abortions1

Embed Size (px)

Citation preview

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    1/54

    Emergent Technologiesfor

    Early Abortions

    Dr Narwadkar MangeshDr Narwadkar Mangesh

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    2/54

    Safe Abortions - Earlier the Better

    Four fold rise in complications with late abortionsFour fold rise in complications with late abortions

    * WHO,* WHO, Tech Report., 1997 Tech Report., 1997

    16

    12

    8

    4

    4 8 12 16 20

    C o m p l

    i c a

    t i o n

    R a

    t e

    %

    Weeks of Amenorrhea

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    3/54

    Safe emerging technologies forearly abortions

    1.1. Manual Vacuum AspirationManual Vacuum Aspiration

    2.2. Medical Methods of AbortionMedical Methods of Abortion

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    4/54

    Manual Vacuum Aspiration

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    5/54

    MVA Kit (Aspirator & Cannula)

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    6/54

    MVA Kit (Aspirator & Cannula)

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    7/54

    Manual Vacuum Aspiration

    Evacuation of uterine contents through aEvacuation of uterine contents through acannula, attached to a hand-held vacuumcannula, attached to a hand-held vacuum

    aspirator.aspirator.The pre created vacuum evacuates theThe pre created vacuum evacuates thecontents of the uterus without damaging thecontents of the uterus without damaging thelining of the uterus.lining of the uterus.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    8/54

    Indications for MVA

    Threatened abortionThreatened abortionInevitable/ Incomplete abortionInevitable/ Incomplete abortionSeptic abortionSeptic abortionMissed abortionMissed abortionBlighted ovumBlighted ovumHydatidiform moleHydatidiform moleRetained placental productsRetained placental products

    Endometrial samplingEndometrial sampling

    8

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    9/54

    contraindications

    Ut > 12 weeksUt > 12 weeks

    Acute cervicitis/PIDAcute cervicitis/PID

    Multiple fibroidsMultiple fibroidsh/o bleeding disorder h/o bleeding disorder

    Suspected uterine perforationSuspected uterine perforation

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    10/54

    FIGO/WHO Endorsement of MVA

    Properly equipped hospitals should abandonProperly equipped hospitals should abandoncurettage and adopt the aspiration methods,curettage and adopt the aspiration methods,selecting Manual Vacuum Evacuation and or selecting Manual Vacuum Evacuation and or Electric AspirationElectric Aspiration

    MVA is an essential basic procedure at FirstMVA is an essential basic procedure at FirstReferral Unit level.Referral Unit level.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    11/54

    Vacuum Aspiration and D&C

    Lesser incidence of haemorrhage, cervicalLesser incidence of haemorrhage, cervicalinjury, lacerations, uterine perforationinjury, lacerations, uterine perforation

    Less dilatation required and hence less painfulLess dilatation required and hence less painful

    and lesser chances of vagal reactionsand lesser chances of vagal reactionsLess pain medication and anaesthesiaLess pain medication and anaesthesia

    Less hospital stayLess hospital stay

    No major O.T. set up required No major O.T. set up required

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    12/54

    MVA and EVA

    Equivalent high levels of effectiveness and lowEquivalent high levels of effectiveness and lowcomplication rates.complication rates.Pressure created is EQUAL in bothPressure created is EQUAL in both

    But with MVA But with MVA No electricity required No electricity requiredSafe in accidental perforationsSafe in accidental perforationsIntact gestation sac in early pregnancyIntact gestation sac in early pregnancyterminationtermination

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    13/54

    MVA ProcedureMVA Procedure

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    14/54

    Cx ripening

    Commnly used agentCommnly used agent

    Tab misoprost 400 microgram 3-4 hoursTab misoprost 400 microgram 3-4 hours

    prior,vaginally prior,vaginallyProstodine 45 min prior I/MProstodine 45 min prior I/M

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    15/54

    Evacuating uterine contents

    Dilate the cervix withcannulae of increasing sizes tillappropriate number is reached,after taking appropriate paincontrol measures

    Connect the cannula to theaspirator

    Move the cannula back and

    forth gently and slowly, rotatingthe cannula and the syringe atthe same time

    15

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    16/54

    Cannula selection

    Depends upon uterine size, period of gestation,Depends upon uterine size, period of gestation,amount of dilatation required to aspirate pocamount of dilatation required to aspirate poc

    Important to have appropriate cannula (retainedImportant to have appropriate cannula (retained products or loss of suction) products or loss of suction)

    4-6 weeks LMP-----4-7mm cannula4-6 weeks LMP-----4-7mm cannula

    7-9 weeks LMP------5-10mm cannula7-9 weeks LMP------5-10mm cannula

    9-12 weeks LMP-----8-12 mm cannula9-12 weeks LMP-----8-12 mm cannula

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    17/54

    Pain managementThe three major sources of discomfort and pain

    during uterine evacuation with MVA are anxiety,cervical dilation and uterine cramping.Verbal reassurance and respectful, supportive care by

    staff throughout the procedure helps to reduce anxietyand decrease pain, and should be a standard part of abortion care.Pain and discomfort during an MVA procedure ca be

    reduced using a combination of verbal support oralmedications, Para cervical block and gentle clinicaltechnique.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    18/54

    Signs that the uterus is empty

    Red or pink foam without tissue passingthrough cannula.

    Gritty sensation over surface of uterus.Cervix gripping over the cannula.Uterus contracting around cannula. Increased

    uterine cramping.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    19/54

    Inspecting the tissue 19

    Strain and Inspectthe evacuated

    tissue

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    20/54

    No visible POC, a lower quantity of tissue thanexpected or an inconclusive tissue sample may

    indicate incomplete abortion, completedspontaneous abortion, failed abortion, suspectedectopic pregnancy or anatomical anomaly.Technical problems that can occur with the

    instrument during an MVA procedure include a fullaspirator, a cannula that is clogged or withdrawn

    prematurely, or a loss of vacuum due to incorrect

    assembly.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    21/54

    Post procedure care/follow up care

    Physical monitoring:Emotional support:

    Contraceptive counseling:Addressing other health issues: anemia,reproductive-tract infections (RTIs, HIV, violence, ,cancer screening.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    22/54

    Post procedure care/follow up care

    Providing discharge instructions.Pain management: Analgesics, NSAID.

    Provision of antibiotics: Research has shown thatroutinely providing antibiotics to womenundergoing MVA reduces infection.Scheduling follow-up care within one week.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    23/54

    Sterilizing

    Agent

    MVA Plus Aspirator and Easy Grip

    Cannulae can be: stetrilized by Autoclaving (121Autoclaving (121

    C for 30 minutes) or soaking inC for 30 minutes) or soaking inGluteraldehyde for 10 hrsGluteraldehyde for 10 hrs

    OR OR High level disinfected by boilingHigh level disinfected by boiling

    for 20 minsfor 20 mins or soaking inor soaking inGluteraldehyde or chlorineGluteraldehyde or chlorinesolution for 20 mins.solution for 20 mins.

    Sterilization / High Level Disinfection

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    24/54

    To sum up - MVA

    MVA is an effective surgical method for terminationMVA is an effective surgical method for terminationof pregnancy up to 12 weeks.of pregnancy up to 12 weeks.

    Increases access and decreases costs as it is OPDIncreases access and decreases costs as it is OPD procedure procedure

    Reduces complication risks and time of procedure asReduces complication risks and time of procedure asit is done under local anaesthesiait is done under local anaesthesia

    Easy to process and handleEasy to process and handle

    Improves patient provider rapportImproves patient provider rapportAllows immediate identification of POCAllows immediate identification of POC

    Excellent backup for failed medical abortionExcellent backup for failed medical abortion

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    25/54

    Medical Methods of Abortion

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    26/54

    What is Medical Methods of Abortion?

    Medical abortion is a non surgical, non invasiveMedical abortion is a non surgical, non invasivemethod of termination of pregnancy bymethod of termination of pregnancy bycombination of drugs.combination of drugs.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    27/54

    Medical Methods of Abortion

    Approved in 30 countriesApproved in 30 countries

    Available for early pregnancy up to 63 daysAvailable for early pregnancy up to 63 days

    High success rate 93-95%High success rate 93-95%

    It takes 8-12 days for the complete processIt takes 8-12 days for the complete process

    Requires minimum 3 visitsRequires minimum 3 visits

    Requires follow up to ensure completion of abortionRequires follow up to ensure completion of abortion

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    28/54

    Why women like Medical Methods of Abortion ?

    No admission required No admission required

    No fear of surgery No fear of surgery

    The method is convenientThe method is convenient

    It enables the woman to look after her home or jobIt enables the woman to look after her home or jobwithout a break without a break

    (Population Council, KEM Hospital Pune 1990-1993)

    C l d d

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    29/54

    Commonly used drugs

    Mifepristone (RU 486)Mifepristone (RU 486)

    invented in 1980initials of pharmaceutical company Roussel-Uclaf 486 is a random laboratory serial number.

    MisoprostolMisoprostol

    Combinations of the two drugs has a high success rateCombinations of the two drugs has a high success rate

    Both the drugs have been approved for use in early Both the drugs have been approved for use in early

    pregnancy termination in India pregnancy termination in India

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    30/54

    Mifepristone RU486Antiprogesterone compound that blocks Progesterone receptor Antiprogesterone compound that blocks Progesterone receptor sites in endometrium, decidua and dislodges the fertilized egg.sites in endometrium, decidua and dislodges the fertilized egg.

    Available as 200 mg TabAvailable as 200 mg Tabmore effective in early pregnancy when progesterone is

    present in lower concentrations due to limited production by

    corpus luteum.When used alone complete abortion rate is 75%When used alone complete abortion rate is 75%

    When used with Misoprostol complete abortion rate is 93-95%When used with Misoprostol complete abortion rate is 93-95%

    Now available in India since April 2002 (Mifegest, Mifeprin, Now available in India since April 2002 (Mifegest, Mifeprin,MTPill, Mifyron etc)MTPill, Mifyron etc)

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    31/54

    Side Effects of Mifepristone

    Serious S/E are rare, however the woman may experienceSerious S/E are rare, however the woman may experience

    Nausea Nausea

    VomitingVomiting

    FatigueFatigue

    DiarrhoeaDiarrhoea

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    32/54

    Misoprostol

    PGE1 analoguePGE1 analogue

    Most commonly used drug for medical methods of Most commonly used drug for medical methods of abortionabortion

    FDA Approved for prevention of gastric ulcer FDA Approved for prevention of gastric ulcer Effective route are oral/vaginal/sublingual/buccalEffective route are oral/vaginal/sublingual/buccal

    Available as 200 micrograms tabletAvailable as 200 micrograms tablet

    Available as Cytotec, Zitotec, Cytolog, Misogon etcAvailable as Cytotec, Zitotec, Cytolog, Misogon etc

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    33/54

    Advantages of Misoprostol

    Low costLow cost

    Stable at room temperatureStable at room temperature

    Effective by different routesEffective by different routes

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    34/54

    Side effects of Misoprostol

    Nausea Nausea

    VomitingVomiting

    Associated with congenital anomalies, if pregnancyAssociated with congenital anomalies, if pregnancycontinuescontinues

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    35/54

    Medical Methods of Abortion& MTP Act

    It can be provided only by MTP certified providers and comesIt can be provided only by MTP certified providers and comesunder the purview of MTP Act.under the purview of MTP Act.MMA upto 7 weeks of gestation can be provided from approvedsites as well as non-approved clinics with referral linkage to

    approved MTP site. The law requires that a certificate of accessto a registered place (i.e. showing that a referral link has beenestablished) from the owner of the approved site must bedisplayed in the clinic where MMA is being provided.

    MMA upto 63 days (9 weeks) can be provided only from theapproved sites.

    Eligibility of the woman

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    36/54

    g yOption of medical methods of abortion should begiven to all women coming to a health facilityseeking termination of pregnancy up to 9 weeks of gestation

    No medical contraindication.

    Frame of mind of the woman, i.e.Acceptability of minimum three visitsAbility to understand the instructions

    Agrees for vacuum aspiration procedure, if failure or excessive bleeding occurs.

    Eligibility of the woman

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    37/54

    g y

    Support from family or others.

    Permission of guardian in case of minor as per MTPAct 1971.Easy access to appropriate health care facility during

    emergency.

    Contraindications

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    38/54

    Contraindicationsfor Medical Methods of Abortion

    Undiagnosed adnexal massUndiagnosed adnexal massConfirmed or suspected ectopic pregnancyConfirmed or suspected ectopic pregnancyIUCD in situIUCD in situChronic Adrenal failureChronic Adrenal failure

    Concurrent long term corticosteroid therapyConcurrent long term corticosteroid therapyInherited PorphyriasInherited Porphyrias

    No access to medical facilities in case of emergency No access to medical facilities in case of emergencyuncontrolled high blood pressure, diabetes, certain heart or uncontrolled high blood pressure, diabetes, certain heart or

    blood vessel diseases, severe liver, kidney or lung disease, or blood vessel diseases, severe liver, kidney or lung disease, or an uncontrolled seizure disorder an uncontrolled seizure disorder

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    39/54

    SCARRED UTERUS

    a uterine scar is not a contraindicationfor first trimester misoprostol induction,

    but that the risk may increase withincreasing gestational age, particularly inthe late second trimester

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    40/54

    Investigations (Recommended)Haemoglobin.Routine Urine Examination.ABO Rh.

    Investigations (Optional) Ultrasound if:She is unsure of LMP.She has irregular periods.Uterine size and menstrual dates do not match.There is suspicion of ectopic / fibroid during P/Vexamination.

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    41/54

    Protocol for Medical Methods of Abortion

    First visit ( Day 1) Mifepristone -First visit ( Day 1) Mifepristone - 200mg given200mg givenorally, after ruling out contraindications.orally, after ruling out contraindications.

    Second visit ( Day 3) Misoprostol 400/800Second visit ( Day 3) Misoprostol 400/800microgms vaginally/orally and kept at the clinicmicrogms vaginally/orally and kept at the clinicfor 4 hoursfor 4 hours

    Third visit (Day 15) Follow up Third visit (Day 15) Follow up to determine if to determine if complete abortion has occurredcomplete abortion has occurred

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    42/54

    h d h h

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    43/54

    Recent research studies have shownthat allowing women to takemisoprostol either vaginally or orallyat home is safe, effective andacceptable to women. However Government of India recommends thatmisoprostol be administered at theclinic and the woman observed for atleast four hours.

    f f

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    44/54

    Outcome of Medical Methods of AbortionParity is not a major factor affecting the outcomeParity is not a major factor affecting the outcome

    Lesser the period of gestation, better the resultsLesser the period of gestation, better the resultsCabezas E, Int J Gynaecol Obstet 1999;63 (suppl 1):S.:1416.Cabezas E, Int J Gynaecol Obstet 1999;63 (suppl 1):S.:1416.

    Most women abort within 4 hrs of Misoprostol administrationMost women abort within 4 hrs of Misoprostol administration

    Of the rest:Of the rest:30% abort within next 24 hrs30% abort within next 24 hrs

    65% abort within next 5 days65% abort within next 5 daysHeaviest bleeding lasts 1 4 hours that coincides with the expulsion

    of POC. Mean period for bleeding is 8 13 days)The incidence of endometritis following medical abortion is lower

    than after surgical abortion

    Day 3-15

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    45/54

    Day 3 15She should preferably avoid going out of station

    till the third visit.She should report if there is no bleeding even 24

    hrs. after taking misoprostol. This may be rare, butthe doctor should consider following possibilities:Rule out ectopic pregnancy and confirm anintrauterine pregnancy.The drug may not have worked and / or more tie is

    needed; repeating the dose may be an option.

    Third visit (Day 15)

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    46/54

    ( y )What to do

    Pelvic examination to confirm completion of abortionUSG if examination does not confirmDebris in the uterus without a gestational sac, pain,

    fever, or excessive vaginal bleeding does notusually require interventionAntibiotics: These are not generally prescribedroutinely but should be given to a woman showing /

    susceptible to infection.She should report back if there are no periodswithin 6 weeks of completion of the abortion

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    47/54

    Failure of the method requiring surgicalintervention

    Incomplete abortion 3 - 5%Incomplete abortion 3 - 5%

    Continuation of pregnancy - 1 -2%Continuation of pregnancy - 1 -2%

    Excessive bleeding - 0.2 2%Excessive bleeding - 0.2 2%(soaking 2 or more maxi pads per hour for 2 hours

    continuously.)

    Contraception after abortion.d h

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    48/54

    Oral pills can be started on 3 rd or 15 th day of the protocol on confirmation of completion of abortion

    process.IUCD can be inserted on day 15 provided the

    presence of infection is ruled out.

    Condom can be used as soon as she resumes sexualactivity after abortion.( It is advised to abstain from sex until theabortion process is complete.. If there is sexual activity after taking thedrugs and before the abortion, it is advised that condom / barrier be used to

    prevent infection.)

    Contraception after abortion..b l l b d f f l

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    49/54

    Tubal ligation can be done after first cycle. However if desirous of concurrent tubal ligation, surgical method

    of abortion is preferred.Injectables can be given on the 3 rd or 15 th day, after

    confirming the completion of the process.

    Vasectomy, if chosen, can be done independent of the procedure.

    An acceptability .If f b i i d 42 f i

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    50/54

    If a future abortion was required, 42 percent of patientswho underwent a surgical abortion would opt for a

    medical abortion; in contrast, only 9 percent of womenwho received medical abortion would prefer a surgicalabortion . However, others have reported greater satisfaction with surgical abortion.

    Medical abortion becomes more painful and lesseffective in women with gestations over 50 days,particularly in those using oral misoprostol . Therefore,

    these women are likely to find vacuum extraction moreacceptable

    Medical Abortion and the Risk of Subsequent

    http://www.uptodate.com/contents/misoprostol-drug-information?source=see_linkhttp://www.uptodate.com/contents/misoprostol-drug-information?source=see_link
  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    51/54

    Adverse Pregnancy Outcomes

    No evidence that a previous medical abortion,as compared with a previous surgical abortion,increases the risk of spontaneous abortion,ectopic pregnancy, pre- term birth, or low birthweight.

    Jasveer Virk, M.S., M.P.H., Jun Zhang, Ph.D., M.D., and Jrn Olsen, M.D., Ph.D. N Engl JMed 2007;357:648-53

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    52/54

    Teratogenic effects on fetus in c/o failure of Teratogenic effects on fetus in c/o failure of medical abortion e.g. Mobius syndrome -medical abortion e.g. Mobius syndrome -congenital facial paralysis with or without limbcongenital facial paralysis with or without limbdefect, cranial nerve defect.defect, cranial nerve defect.

    Because of a potential teratogenic risk, surgicalabortion is recommended in cases of failed

    pregnancy termination

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    53/54

    To sum up Medical Methods of Abortion

    Medical methods of termination of pregnancy haveMedical methods of termination of pregnancy haveincreased the choices for women and doctorsincreased the choices for women and doctors

    Effective counseling increases the chances of success of Effective counseling increases the chances of success of medical methods of abortionmedical methods of abortion

    Medical methods of abortion can go a long way inMedical methods of abortion can go a long way in

    increasing access to Safe Abortionsincreasing access to Safe Abortions

  • 7/31/2019 2 Emergent Techniologies for Early Abortions1

    54/54